Detection of Low Copy Numbers of HIV-1 Proviral DNA in Patient PBMCs by a High-Input, Sequence-Capture PCR (Mega-PCR)

Journal of Medical Virology

Volumn 72, Issue 1, 2004, Pages 1-9

  Böni, Jürg ^a   Shah, Cyril ^a   Flepp, Markus ^b   Lüthy, Ruedi ^b,c   Schüpbach, Jörg ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Swiss Aids Care International   (Switzerland)

Author keywords

Diagnosis; HIV; Retrovirus; Western blot indeterminate

Indexed keywords

GAG PROTEIN; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DNA DETERMINATION; DNA EXTRACTION; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMID; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SERODIAGNOSIS; VIRUS DETECTION; VIRUS DIAGNOSIS; VIRUS GENE;

ADULT; CHILD, PRESCHOOL; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE DOSAGE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; LEUKOCYTES, MONONUCLEAR; PLASMIDS; POLYMERASE CHAIN REACTION; PROVIRUSES;

HUMAN IMMUNODEFICIENCY VIRUS 1; UNIDENTIFIED RETROVIRUS;

EID: 0344012541     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10535     Document Type: Article

References (61)

1. Andersson S, Norrgren H, da Silva Z, Biague A, Bamba S, Kwok S, Christopherson C, Biberfeld G, Albert J. 2000. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: Significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch Intern Med 160:3286-3293.
2. Anonymous. 1989. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR Morb Mortal Wkly Rep 38:1-7.
3. Babu PG, Rawal BD, Khayam-Bashi H, Vyas GN. 1993. Detection of exceedingly low levels of HIV proviral DNA in multimillion peripheral blood mononuclear cells by PCR. PCR Methods Appl 3:63-64.
4. Bagnarelli P, Menzo S, Valenza A, Paolucci S, Petroni S, Scalise G, Sampaolesi R, Manzin A, Varaldo PE, Clementi M. 1995. Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds. J Clin Microbiol 33:16-23.
5. Barlow KL, Tosswill JH, Parry JV, Clewley JP. 1997. Performance of the Amplicor human immunodeficiency virus type 1 PCR and analysis of specimens with false-negative results. J Clin Microbiol 35:2846-2853.
6. Brugiere O, Vokurka M, Lecossier D, Mangiapan G, Amrane A, Milleron B, Mayaud C, Cadranel J, Hance AJ. 1997. Diagnosis of smear-negative pulmonary tuberculosis using sequence capture polymerase chain reaction. Am J Respir Crit Care Med 155:1478-1481.
7. Burgisser P, Vernazza P, Flepp M, Böni J, Tomasik Z, Hummel U, Pantaleo G, Schüpbach J. 2000. Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV cohort study. J Acquir Immune Defic Syndr 23:138-144.
8. Busch MP, Lee LL, Satten GA, Henrard DR, Farzadegan H, Nelson KE, Read S, Dodd RY, Petersen LR. 1995. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: Implications for screening of blood and tissue donors. Transfusion 35:91-97.
9. Busch MP, Kleinman SH, Williams AE, Smith JW, Ownby HE, Laycock ME, Lee LL, Pau CP, Schreiber GB. 1996. Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors. The retrovirus epidemiology donor study. Transfusion 36:37-44.
10. Böni J, Schüpbach J. 1993a. Primer extension analysis provides a sensitive tool for the identification of PCR-amplified DNA from HIV-1. J Virol Methods 42:309-322.
11. Böni J, Schüpbach J. 1993b. Sensitive and quantitative detection of PCR-amplified HIV-1 DNA products by an enzyme linked immunoassay following solution hybridization with two differently labelled oligonucleotide probes. Mol Cell Probes 7:361-371.
12. Böni J, Pyra H, Schüpbach J. 1996. Sensitive detection and quantification of particle-associated reverse transcriptase in plasma of HIV-1-infected individuals by the product-enhanced reverse transcriptase (PERT) assay. J Med Virol 49:23-28.
13. Chadwick N, Bruce I, Davies M, van Gemen B, Schukkink R, Khan K, Pounder R, Wakefield A. 1998. A sensitive and robust method for measles RNA detection. J Virol Methods 70:59-70.
14. Debyser Z, Van Wijngaerden E, Van Laethem K, Beuselinck K, Reynders M, De Clercq E, Desmyter J, Vandamme AM. 1998. Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV type 1 subtype G strain. AIDS Res Hum Retroviruses 14:453-459.
15. Deiss V, ven Overbeck J, Furrer H J, Germann D, Matter L, Telenti A. 1994. [Epidemiology of HIV-1 infection in Bern-Application of molecular methods]. Schweiz Med Wochenschr 124:539-544.
16. Dornadula G, Zhang H, VanUitert B, Stern J, Livornese L, Jr., Ingerman MJ, Witek J, Kedanis RJ, Natkin J, DeSimone J, Pomerantz RJ. 1999. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy. JAMA 282:1627-1632.
17. Ercolani L, Florence B, Denaro M, Alexander M. 1988. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 263:15335-15341.
18. Escaich S, Wallon M, Baginski I, Ritter J, Philippe N, Bertrand Y, Claris O, Raudrant D, Sepetjan M, Trepo C. 1991. Comparison of HIV detection by virus isolation in lymphocyte cultures and molecular amplification of HIV DNA and RNA by PCR in offspring of seropositive mothers. J Acquir Immune Defic Syndr 4:130-135.
19. Gomes P, Taveira NC, Pereira JM, Antunes F, Ferreira MO, Lourenco MH. 1999. Quantitation of human immunodeficiency virus type 2 DNA in peripheral blood mononuclear cells by using a quantitative-competitive PCR assay. J Clin Microbiol 37:453-456.
20. Gottlieb GS, Sow PS, Hawes SE, Ndoye I, Redman M, Coll-Seck AM, Faye-Niang MA, Diop A, Kuypers JM, Critchlow CW, Respess R, Mullins JI, Kiviat NB. 2002. Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) Type 1- and HIV-2-infected individuals from Senegal, West Africa. J Infect Dis 185:905-914.
21. Gutierrez M, Soriano V, Bravo R, Vallejo A, Gonzalez-Lahoz J. 1994. Seroreversion in patients with end-stage HIV infection. Vox Sang 67:238-239.
22. Healey DS, Bolton WV. 1993. Apparent HIV-1 glycoprotein reactivity on Western blot in uninfected blood donors. Aids 7:655-658.
23. Heermann KH, Seitz H, Thomssen R. 1996. Capture and RT-PCR of hepatitis C virus RNA with safety primers. J Virol Methods 59:33-43.
24. Henrard DR, Phillips J, Windsor I, Fortenberry D, Korte L, Fang C, Williams AE. 1994. Detection of human immunodeficiency virus type 1 p24 antigen and plasma RNA: Relevance to indeterminate serologic tests. Transfusion 34:376-380.
25. Hughes MD, Johnson VA, Hirsch MS, Bremer JW, Elbeik T, Erice A, Kuritzkes DR, Scott WA, Spector SA, Basgoz N, Fischl MA, D'Aquila RT. 1997. Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 protocol virology substudy team. Ann Intern Med 126:929-938.
26. Hughes MS, James G, Ball N, Scally M, Malik R, Wigney DI, Martin P, Chen S, Mitchell D, Love DN. 2000. Identification by 16S rRNA gene analyses of a potential novel mycobacterial species as an etiological agent of canine leproid granuloma syndrome. J Clin Microbiol 38:953-959.
27. Jackson JB, MacDonald KL, Cadwell J, Sullivan C, Kline WE, Hanson M, Sannerud KJ, Stramer SL, Fildes NJ, Kwok SY, et al. 1990. Absence of HIV infection in blood donors with indeterminate Western blot tests for antibody to HIV-1. N Engl J Med 322:217-222.
28. Kline NE, Schwarzwald H, Kline MW. 2002. False negative DNA polymerase chain reaction in an infant with subtype C human immunodeficiency virus 1 infection. Pediatr Infect Dis J 21:885-886.
29. Lafeuillade A, Poggi C, Pellegrino P, Profizi N. 1996. Quantitative molecular monitoring of HIV-1 RNA during antiretroviral therapy. Infection 24:412-418.
30. Lee TH, el-Amad Z, Reis M, Adams M, Donegan EA, O'Brien TR, Moss AR, Busch MP. 1991. Absence of HIV-1 DNA in high-risk seronegative individuals using high-input polymerase chain reaction. Aids 5:1201-1207.
31. Legler TJ, Kohler M, Heermann KH. 1999. High-throughput extraction, amplification, and detection (HEAD) of HCV-RNA in individual blood donations. J Clin Virol 13:95-103.
32. Lindback S, Thorstensson R, Karlsson AC, von Sydow M, Flamholc L, Blaxhult A, Sonnerborg A, Biberfeld G, Gaines H. 2000. Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska institute primary HIV infection study group. Aids 14:2333-2339.
33. Loisy F, Le Cann P, Pommepuy M, Le Guyader F. 2000. An improved method for the detection of Norwalk-like caliciviruses in environmental samples. Lett Appl Microbiol 31:411-415.
34. Manak MM, Snider JV, Petersen D, Frederick W, Barnes S, Huang DP. 1993. Use of PCR for detection of HIV-1 sequences in babies born to seropositive mothers. Ann NY Acad Sci 693:255-257.
35. Mangiapan G, Vokurka M, Schouls L, Cadranel J, Lecossier D, van Embden J, Hance AJ. 1996. Sequence capture-PCR improves detection of mycobacterial DNA in clinical specimens. J Clin Microbiol 34:1209-1215.
36. Marsh I, Whittington R, Millar D. 2000. Quality control and optimized procedure of hybridization capture-PCR for the identification of Mycobacteriurn aviurn subsp. paratuberculosis in faeces. Mol Cell Probes 14:219-232.
37. Meng Q, Wong C, Rangachari A, Tamatsukuri S, Sasaki M, Fiss E, Cheng L, Ramankutty T, Clarke D, Yawata H, Sakakura Y, Hirose T, Impraim C. 2001. Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA. J Clin Microbiol 39:2937-2945.
38. Midthun K, Garrison L, Clements ML, Farzadegan H, Fernie B, Quinn T. 1990. Frequency of indeterminate Western blot tests in healthy adults at low risk for human immunodeficiency virus infection. The NIAID AIDS vaccine clinical trails network. J Infect Dis 162:1379-1382.
39. Migali E, Mariotti D, Lovari A, Tenani T, Imperiali P, Ozzola G. 1993. HIV-1: Absence of infection in subjects with indeterminate Western blot. Allergol Immunopathol (Madr) 21:61-65.
40. O'Brien WA, Hartigan PM, Daar ES, Simberkoff MS, Hamilton JD. 1997. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA cooperative study group on AIDS. Ann Intern Med 126:939-945.
41. Petrik J, Pearson GJ, Allain JP. 1997. High throughput PCR detection of HCV based on semiautomated multisample RNA capture. J Virol Methods 64:147-159.
42. Regan PM, Margolin AB. 1997. Development of a nucleic acid capture probe with reverse transcriptase-polymerase chain reaction to detect poliovirus in groundwater. J Virol Methods 64:65-72.
43. Rhodes D, Solomon A, Bolton W, Wood J, Sullivan J, Learmont J, Deacon N. 1999. Identification of a new recipient in the Sydney Blood Bank Cohort: A long-term HIV type 1-infected seroindeterminate individual. AIDS Res Hum Retroviruses 15:1433-1439.
44. Roring S, Hughes MS, Skuce RA, Neill SD. 2000. Simultaneous detection and strain differentiation of Mycobacterium bovis directly from bovine tissue specimens by spoligotyping. Vet Microbiol 74:227-236.
45. Schockmel GA, Yerly S, Perrin L. 1997. Detection of low HIV-1 RNA levels in plasma. J Acquir Immune Defic Syndr Hum Retrovirol 14:179-183.
46. Schubert M, Harmison GG, Richardson CD, Meier E. 1985. Expression of a cDNA encoding a functional 241-kilodalton vesicular stomatitis virus RNA polymerase. Proc Natl Acad Sci USA 82:7984-7988.
47. Schüpbach J. 1999. Human immunodeficiency viruses. In: e.i.c. Murray Patrick R, editor. Manual of clinical microbiology, 7th Edn. Washington, DC: American Society for Microbiology, pp 847-870.
48. Shad G, Wilson WC, Mecham JO, Evermann JF. 1997. Bluetongue virus detection: A safer reverse-transcriptase polymerase chain reaction for prediction of viremia in sheep. J Vet Diagn Invest 9:118-124.
49. Shah C, Böni J, Bisset LR, Seebach D, Schüpbach J. 2003. Ultrasensitive and specific detection of porcine endogenous retrovirus (PERV) using a sequence-capture real-time PCR approach. J Virol Methods 109:209-216.
50. Simon F, Matheron S, Tamalet C, Loussert-Ajaka I, Bartczak S, Pepin JM, Dhiver C, Gamba E, Elbim C, Gastaut JA, et al. 1993. Cellular and plasma viral load in patients infected with HIV-2. AIDS 7:1411-1417.
51. Soriano V, Gomes P, Heneine W, Holguin A, Doruana M, Antunes R, Mansinho K, Switzer WM, Araujo C, Shanmugam V, Lourenco H, Gonzalez-Lahoz J, Antunes F. 2000. Human immunodeficiency virus type 2 (HIV-2) in Portugal: Clinical spectrum, circulating subtypes, virus isolation, and plasma viral load. J Med Virol 61:111-116.
52. Stinear T, Davies JK, Jenkin GA, Hayman JA, Oppedisano F, Johnson PD. 2000. Identification of Mycobacterium ulcerans in the environment from regions in Southeast Australia in which it is endemic with sequence capture-PCR. Appl Environ Microbiol 66:3206-3213.
53. Stoeckli TC, Steffen-Klopfstein I, Erb P, Brown TM, Kalish ML. 2000. Molecular epidemiology of HIV-1 in Switzerland: Evidence for a silent mutation in the C2V3 region distinguishing intravenous drug users from homosexual men. Swiss HIV cohort study. J Acquir Immune Defic Syndr 23:58-67.
54. Sun R, Ku J, Jayakar H, Kuo JC, Brambilla D, Herman S, Rosenstraus M, Spadoro J. 1998. Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 36:2964-2969.
55. Tano H, Fan K, Kitajima MA, Kasai K, Tamatsukuri S, Furuichi Y, Hayashi T, Kondo M, Imai M. 1995. Prior enrichment of human immunodeficiency virus DNA with probe DNA particles for efficient PCR diagnosis. J Clin Microbiol 33:2489-2491.
56. van Doorn LJ, Kleter B, Voermans J, Maertens G, Brouwer H, Heijtink R, Quint W. 1994a. Rapid detection of hepatitis C virus RNA by direct capture from blood. J Med Virol 42:22-28.
57. van Doorn LJ, Shyamala V, Han JH, Kleter GE. 1994b. HCV RNA detection in heparinized blood by direct genomic RNA capture onto paramagnetic particles. J Virol Methods 48:339-341.
58. Yolken RH, Sierra-Honigmann AM, Viscidi RP. 1991. Solid phase capture method for the specific amplification of microbial nucleic acids-Avoidance of false-positive and false-negative reactions. Mol Cell Probes 5:151-156.
59. Young NL, Shaffer N, Chaowanachan T, Chotpitayasunondh T, Vanparapar N, Mock PA, Waranawat N, Chokephaibulkit K, Chuachoowong R, Wasinrapee P, Mastro TD, Simonds RJ. 2000. Early diagnosis of HIV-1-infected infants in Thailand using RNA and DNA PCR assays sensitive to non-B subtypes. J Acquir Immune Defic Syndr 24:401-407.
60. Zhu T, Corey L, Hwangbo Y, Lee JM, Learn GH, Mullins JI, McElrath MJ. 2003. Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals. J Virol 77:6108-6116.
61. Zimmermann K, Plaimauer B, Schogl D, Mannhalter JW. 1997. Detection of false-negative results in nested primer PCR of proviral HIV-1 DNA. Biotechniques 23:882-884, 886-888.